Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind active-controlled multicenter study of CB275 sublingual film for insomnia with difficulty initiating sleep
CTR20262823Phase 2Active
- Sponsor
- Chengbang Pharmaceutical
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CB275 in chronic insomnia, sponsored by Chengbang Pharmaceutical. Started Jul 2026; status: active.
02
Drugs
CB275
03
Conditions
chronic insomnia
Beyond the preview
Go deeper on CTR20262823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262823.